Archive for the ‘Stem Cell Therapy’ Category

Sep 18, 2020

Stem Cell Therapy May Reduce Pain in Pets

Posted by Bob under Pain in Pets, Stem Cell Therapy

As Animal Pain Awareness Month continues, we wanted to share some information about how stem cells may relieve pain in pets. We frequently share stories about dogs with osteoarthritis who regain mobility and a better quality of life after receiving VetStem Cell Therapy. While stem cells utilize multiple mechanisms of action, one primary benefit of stem cells is their ability to reduce inflammation and pain.

Pain in Pets

As we mentioned in last week’s blog, pets can suffer from acute and chronic pain. Pain in pets can result from a variety of causes and there are three primary classifications of pain:

  • Nociceptive – caused by noxious stimulation (injury/physical damage, exposure to chemicals or exposure to extreme temperatures)
  • Inflammatory – caused by acute or chronic inflammation
  • Neuropathic – from damage to an element of the nervous system

Stem Cells are Anti-Inflammatory

One major mechanism of action is the ability of stem cells to down regulate inflammation. By reducing inflammation, stem cells promote healing and increase comfort. When used to treat osteoarthritis, stem cells may promote cartilage regrowth and therefore healthier and less painful joints.

Stem Cells Act Directly on Pain

While a reduction in inflammation can lead to increased comfort, current literature supports that stem cells have the ability to address both acute and chronic pain directly. Recently, there have been studies to evaluate stem cells’ direct effects on modulating pain. Stem cells have been shown to secrete pain blocking cytokines (small proteins), which can have opioid-like effects. Stem cells have also shown the ability to reduce neuroinflammation (inflammation of the nervous tissue).

If you think your pet may benefit from stem cell therapy, contact us for a list of VetStem providers in your area.

Share
Sep 4, 2020

VetStem Raises the Bar for Veterinary Stem Cell Therapy

Posted by Bob under Stem Cell Therapy, VetStem Biopharma

As the first company to provide adipose derived stem cell services to veterinarians in the United States and Canada, VetStem has processed nearly 14,000 patient samples resulting in over 30,000 stem cell treatments for animals. VetStem Cell Therapy is primarily used for the treatment of orthopedic conditions such as osteoarthritis as well as torn tendons and ligaments in dogs, cats, and horses. In addition to domestic animals, VetStem has worked with multiple exotic animal organizations to provide stem cell therapy for several exotic species. (Read last week’s blog about Brody the bear!)

Veterinarians have also used VetStem Cell Therapy to treat several “non-standard” indications. Some of these include feline chronic kidney disease, inflammatory bowel disease, feline gingivostomatitis, and canine keratoconjunctivitis sicca (“dry eye). While we are still researching the full capabilities of stem cells, veterinarians have seen promising results when treating these and other conditions with VetStem Cell Therapy.

VetStem has been providing stem cell processing services to veterinarians for their patients for over 17 years. We pride ourselves on providing the highest quality stem cell processing services for all patient samples. Our laboratory technicians undergo extensive training and dedicate the majority of their workday to stem cell processing. All patient samples are processed in bio-safety cabinets in hepa-filtered cleanrooms. We take sterility and patient safety very seriously.

In addition, VetStem determines the cell yield and viability of each sample to ensure an accurate dose prior to shipment. Using cell counting technology allows us to know the number of cells packaged in each stem cell injection. We continually draw upon existing and new research as well as 17+ years of experience to determine appropriate cell numbers.

If you think your pet may benefit from stem cell therapy, speak to your veterinarian about the possibility of using VetStem Cell Therapy. We have provided a letter you can take to your vet to help them get better acquainted with the science behind stem cell therapy and VetStem’s services. Or you can contact us to receive a list of VetStem providers in your area.  

Share
Aug 28, 2020

Brody the Bear Receives VetStem Cell Therapy

Posted by Bob under VetStem Cell Therapy

Brody is a Florida black bear that had a pretty rough start in life. He was found abandoned at approximately 3 weeks of age in Ocala National Forest. The Florida Fish and Wildlife Conservation Commission were unsuccessful in finding his mother and determined he had severe respiratory issues and a weak suckling response. Because he was abandoned at such a young age, he was not a candidate for release. Thus, he was transferred to the Brevard Zoo for long-term care. Fortunately for Brody, Zoo team members nursed him back to health and continue to give him hours of exercise and socialization.

Not Out of the Woods Yet

In May, when Brody was approximately 4 months old, caregivers noticed that Brody’s abdomen was sensitive and that he was repeatedly licking the area. He was anesthetized for an examination and it was determined that Brody has a condition similar to hip dysplasia in dogs. His hip joints are malformed and, if left untreated, will lead to severe pain and osteoarthritis. In an effort to avoid this fate, it was determined that Brody would undergo a corrective surgery known as juvenile pubic symphysiodesis (JPS).

Dr. Christiansen injecting Brody’s own stem cells into his hip

A Skilled Surgeon Steps Up to the Plate

As luck would have it, Dr. Jeff Christiansen, board-certified surgeon and avid stem cell user, was contacted to perform Brody’s surgery. Dr. Christiansen has performed JPS on puppies with great success and felt that Brody would be a good candidate for the procedure. While he had Brody on the operating table, he collected some fat for stem cell processing.

Brody’s fat was received at the VetStem laboratory where his stem cells were extracted and put into culture to grow stem cell doses. Once complete, three stem cell doses were shipped back to Dr. Christiansen. Brody received one injection in each hip as well as one intravenous injection.

A Happy Ending

According to the Brevard Zoo, Brody is recovering well. It will be quite some time before they can evaluate the long-term effectiveness of the surgery but the good news is, Brody has 15 stem cell doses banked for potential future use. When VetStem Cell Therapy is used in conjunction with surgery, the stem cells act to reduce pain and inflammation and to promote healing.

Brody is not the first bear that VetStem has helped. In 2018, Francis, a sun bear at the San Diego Zoo, received VetStem Cell Therapy for arthritis, using his own stem cells. You can read Francis’ stem cell story here.

Share
Aug 14, 2020

Golden Retriever Receives VetStem Cell Therapy for Hip Arthritis

Posted by Bob under Dog Arthritis, VetStem Cell Therapy

When Daisey was approximately six years old, she began showing symptoms of osteoarthritis in her hips. A typical fun-loving Golden, Daisey enjoys fetch, running at the dog park, and playing with her canine sibling. When she began to limp after her favorite activities, her owners knew there was a problem.  She started having trouble walking up stairs and would occasionally yelp in pain.

Daisey

A trip to the veterinarian revealed Daisey has osteoarthritis in her hips as a result of bilateral hip dysplasia. Her owners decided against surgery and instead looked into stem cell therapy. Her veterinarian, Dr. Rob Landry of Colorado Center for Animal Pain Management, has extensive experience with VetStem Cell Therapy and determined Daisey was a good candidate for the procedure.

Dr. Landry collected fat tissue from Daisey’s abdomen, which was shipped to the VetStem laboratory in California. VetStem lab technicians processed the tissue to extract and concentrate Daisey’s stem and regenerative cells. Three injectable stem cell doses were shipped back to Dr. Landry. Approximately 48 hours after the fat tissue collection, Daisey received injections of her own stem cells into each hip and intravenously.

After the procedure, Daisey’s owners noticed improvement. First, they noticed that Daisey was able to rise from lying down with less difficulty. Additionally, climbing stairs became less of a challenge for Daisey. Eventually, she began to play more and is now able to take long walks with her owners. Her owner stated, “There is a contented look on her face and a twinkle in her eyes. So far life is good.”

Unfortunately, Daisey’s story is not uncommon. Approximately 1 in 5 adult dogs are affected by arthritis. OA can be caused by a number of factors including abnormal joint conformation or development, injury, and obesity. In addition, some dog breeds, like Golden Retrievers, are predisposed to the disease. Fortunately, stem cells have shown the ability to down-regulate inflammation and pain, which can lead to an increase in an arthritic dog’s quality of life. If you think your dog may benefit from VetStem Cell Therapy, speak to your veterinarian or contact us to receive a list of VetStem providers in your area.

Share
Jul 31, 2020

FDA Approved Stem Cell Clinical Trial for COVID-19

Posted by Bob under COVID-19, Stem Cell Therapy

It is with immense pride that we announce our human company, Personalized Stem Cells, recently received FDA approval to treat COVID-19 patients in an upcoming clinical trial. Read PSC’s blog below:

Personalized Stem Cells (PSC) recently received FDA approval to treat COVID-19 patients with stem cells in an upcoming clinical trial. In April, we announced that we filed an expedited IND at the request of the White House Coronavirus Task Force to treat hospitalized COVID-19 patients. This approval is incredibly significant because patients will be treated with disease-screened, quality tested donor cells as opposed to their own stem cells. This is known as allogeneic stem cell therapy and is different from PSC’s current FDA approved clinical trial in which patients receive their own stem cells (autologous) to treat knee osteoarthritis.

Stem Cell Therapy for COVID-19

PSC has become a leader in the field, recently publishing a landmark peer-reviewed scientific article on the rationale behind using stem cells to treat COVID-19. Mesenchymal stem cells (MSCs) have demonstrated the capacity to inhibit lung damage, reduce inflammation, dampen immune responses and aid with alveolar fluid clearance. Additionally, MSCs produce molecules that are antimicrobial and reduce pain. Recently, the application of MSCs in the context of ongoing COVID-19 disease and other viral respiratory illnesses has demonstrated reduced patient mortality and, in some cases, improved long-term pulmonary function.

Based on information out of Israel, China, Spain and the United States, stem cells have shown promising effectiveness in the treatment of the major medical lung issues caused by COVID-19. Israel recently announced 100% recovery in seven COVID-19 patients who were treated with stem cell therapy. Spanish medical investigators reported on an adipose stem cell study in which 13 COVID-19 patients were treated using a protocol very similar to the one just approved for PSC. According to the results, the mortality rate in the treated patients was significantly decreased.

FDA Approved Clinical Trial: CoronaStem 1

The initial clinical trial, named CoronaStem 1, will include 20 COVID-19 patients hospitalized in California. Once complete, PSC hopes to move into a larger Phase 2 clinical study and potentially into FDA Expanded Use programs or Emergency Use Authorization, which could allow for many more patients to be treated.

In order to rapidly ramp up the production of stem cells for use in the clinical trial, PSC collaborated with Calidi Biotherapeutics, a biotechnology company based in San Diego, California. Calidi provided disease-screened, quality stem cell lines to PSC, enabling us to accelerate the stem cell drug manufacturing process. In addition, sister company and CRO, VetStem Biopharma, provided manufacturing and regulatory support to help make FDA approval a reality.

PSC is not currently soliciting patients for inclusion in CoronaStem 1 due to the limited number of hospitals participating in the study. For more information regarding future clinical trials, please contact us here.

Share
Jul 17, 2020

Horse Receives VetStem Cell Therapy for Ligament Injuries

Posted by Bob under Horse Injuries, VetStem Cell Therapy

Heartbeat is a 22-year-old Oldenberg gelding. When he was 16, he started to show signs of lameness in his left front leg. Extensive examinations and diagnostics revealed his lameness was due to injuries to his lateral collateral and impar ligaments in his left front hoof.

Heartbeat in the Jumper Ring

His veterinarian, Dr. Patricia Doyle of Mid-Atlantic Equine Medical Center, recommended treatment with VetStem Cell Therapy and began the process by collecting fat from Heartbeat’s tailhead. The fat was processed at the VetStem laboratory and 3 syringes of Heartbeat’s own stem cells were shipped back to Dr. Doyle for injection into his injured leg.

In addition to VetStem Cell Therapy, Dr. Doyle recommended a slow, regimented rehabilitation program for approximately 8-12 months following Heartbeat’s stem cell treatment. Veterinarian’s may or may not recommend rehabilitation in conjunction with VetStem Cell Therapy depending on several factors such as the condition being treated and the severity of the condition. Some other horses that benefited from rehab after receiving VetStem Cell Therapy are Jesse, Atlas, and Woody.

Following stem cell therapy and one full year of rehab, Heartbeat returned to the jumper ring and has competed successfully at the lower levels for the past 6 years. Now, at age 22, his owner reports, “He remains sound working six days a week on average and still winning in the show ring.” If your horse has suffered an injury or is suddenly lame, speak to your veterinarian about whether or not VetStem Cell Therapy may help. Or contact us to receive a list of VetStem providers in your area.

Share
Jul 10, 2020

Vet has Own Dog Treated with VetStem Cell Therapy for Arthritis

Posted by Bob under Dog Arthritis, VetStem Cell Therapy

Emma is a 12-year-old Australian cattle dog. She has arthritis in her elbows and carpus (wrist) and also has spondylosis, a spinal condition in which bony spurs form along the vertebrae. Fortunately for Emma, her mom is a veterinarian and elected to have Emma treated with VetStem Cell Therapy.

In 2018, Emma had her fat collected to begin the process for stem cell therapy. Her initial treatment consisted of three joint injections for her elbows and right carpus, one intravenous injection, and one injection that was given along the muscles of her spine. She responded well to treatment.

After approximately one year, Emma began to slow down again. Her veterinarian requested that Emma’s stem cells be put into culture to grow more stem cell doses for treatment. Once the culture process was complete, Emma received a second round of stem cell injections just over one year after her first treatment.

Again, Emma responded well to the stem cell treatment but, according to her mom, began to show signs of discomfort approximately one year after her second stem cell treatment. Her mom stated, “What we notice is weakness to her back legs and mild limping on her front legs. She will also lick at her carpi and elbows when her pain is acting up. When her rear legs are weak, we notice she has trouble jumping onto the couch. She also needs to stop and rest frequently when we take her on walks.” Emma received a third stem cell treatment in June of this year. Her mom stated, “I know she would not be alive today if it wasn’t for the stem cell treatment.”

Emma’s story is not uncommon. Many VetStem patients have undergone repeat injections when their symptoms start to flare up again. One such patient is Bodie, the champion Bird Dog with hip dysplasia. Fortunately, VetStem offers stem cell storage for patients who receive VetStem Cell Therapy. If available, the stored stem cells can be used for future treatments as needed. For more information about cell storage, read our recent blog on the subject.

Share
May 29, 2020

VetStem Biopharma Centennial Club

As the first company in the United States to provide adipose-derived stem cell processing services to veterinarians and their patients, VetStem pioneered the use of regenerative stem cells in veterinary medicine. Since 2003, VetStem has trained nearly 5,000 veterinarians across the United States and Canada to perform VetStem Cell Therapy. We have processed fat samples for over 14,000 patients and 30 different species of animals.

Twelve of our VetStem trained veterinarians have provided VetStem services for over 100 of their patients. The “Centennial Club,” as we like to call them, are among the most experienced adipose-derived stem cell providers in the country. Seven of the Centennial Club members are small animal veterinarians while the other five are equine veterinarians. The Centennial Club members are:

Small Animal
Dr. Kim Carlson of North Peninsula Veterinary Surgical Group
Dr. Jamie Gaynor of Peak Performance Veterinary Group
Dr. Jeff Christiansen of Superior Veterinary Surgical Solutions
Dr. Allyson Berent of Animal Medical Center of New York
Dr. Adam Gassel of Blue Pearl Pet Hospital of Irvine
Dr. Keith Clement of Burnt Hills Veterinary Hospital
Dr. Tim McCarthy formerly of Cascade Veterinary Referral Center

Equine
Dr. Ross Rich of Regenerative Therapy Consulting
Dr. Martin Gardner of Western Performance Equine
Dr. John McCarroll of Equine Medical Associates
Dr. Bill Hay of Tryon Equine Hospital
Dr. Scott Reiners of Mountain View Equine Hospital

Each of the above veterinarians has made VetStem Cell Therapy an integral part of their veterinary practice. They are all experienced in case selection and have seen many positive outcomes. We think it’s worth mentioning that two of the above veterinarians have reached even bigger milestones. Dr. Martin Gardner has surpassed 500 stem cell cases and Dr. John McCarroll has over 250 stem cell cases. Additionally, there are four more veterinarians who are approaching 100 stem cell cases.

Stem cells are regenerative cells that can differentiate into many tissue types. In both small animals and horses, stem cell therapy is most often used to treat orthopedic conditions such as osteoarthritis and injured tendons and ligaments. VetStem Cell Therapy has shown to reduce pain and lameness and improve quality of life and return to work for horses. If you would like to locate a VetStem provider near you, please contact us.

Share
May 1, 2020

PSC Prepares to Launch COVID-19 Clinical Trial – You Can Help

Posted by Bob under COVID-19, Stem Cell Therapy

Our human stem cell company, Personalized Stem Cells, Inc. (PSC), recently announced that they filed a request with the FDA for expedited review of an Investigational New Drug (IND) application for the treatment of COVID-19 patients with stem cells. PSC was asked by the White House Coronavirus Task Force to apply for expedited review through a new FDA program called the Coronavirus Therapeutic Accelerator Program (CTAP). CTAP was launched to help expedite the approval process of clinical trials for promising COVID-19 therapies.

Stem Cells for COVID-19

Recent studies evaluating the effects of stem cell therapy in COVID-19 patients have come out of China and Israel showing strikingly positive results. Stem cells have anti-inflammatory properties and the ability to reduce scar tissue formation. Stem cell therapy has the potential to reduce the serious lung complications that occur as a result of infection with COVID-19. The goal of treatment is to reduce time spent in the ICU, reduce ventilator needs, and increase chances of survival for seriously ill COVID-19 patients.

PSC has scaled up production of stem cells in their FDA-inspected facilities to be ready to provide stem cell treatments upon FDA approval. If approved, the initial COVID-19 clinical trial, termed “CoronaStem 1,” will provide treatment for twenty hospitalized COVID-19 patients with serious complications. The first trial will be conducted in a limited number of local San Diego hospitals. PSC anticipates additional approvals and potential compassionate use in the future to allow for many more patients to be treated.

How can you help?

As a small business, PSC is utilizing their own resources to ramp up stem cell production. However, supplies and laboratory technicians are necessary to further increase production of stem cells. PSC plans to provide stem cell treatments to COVID-19 patients at no cost to the patient which requires additional money to pay the doctors, nurses and other healthcare workers who will be performing the clinical trial. Thus, PSC is reaching out to the public for donations to help in this fight against COVID-19. Your tax-deductible donation will allow PSC to provide stem cell treatments for as many COVID-19 patients as possible. All donations will go towards increasing stem cell production and paying doctors, nurses, technicians, and all those involved in performing the medical procedures for the clinical trial.

While the COVID-19 pandemic has impacted us all, many of us are looking for ways in which we can help. PSC has partnered with the San Diego Foundation, a 501c3 organization, to collect tax-deductible donations to further PSC’s efforts. Learn more about how your donation can help PSC fight COVID-19.

You can make a difference! Click here to donate today.

Share
Nov 22, 2019

Documentary Featuring VetStem Receives Another Award

Posted by Bob under VetStem Cell Therapy

In our blog about translational medicine, we announced that VetStem was featured in an award-winning documentary, Animal Pharm: Where Beasts Meet BiotechThe film was included in the Brentwood and Pacific Palisades International Film Festival in Los Angeles, California where it received the award for Best Nature and Animals Film.

The documentary focuses on regenerative veterinary medicine as a means of improving the quality of life for domestic and wild animals and heavily features VetStem, including an interview with VetStem Founder and CEO Dr. Bob Harman.  Dr. Harman explains that when he first conceived of and formed VetStem, he was called “crazy.” Over time however the thinking has evolved so that regenerative medicine is now regarded as a legitimate and valuable tool for veterinarians.

We recently received the exciting news that the film will be featured in the Palm Beach International Mini Movie and Film Festival on December 9th in Palm Beach, Florida.  Not only will the film be featured, the producers will also be presented with the award for Best Documentary!  Congratulations to everyone involved in the making of the film.

We are proud to be a part of this film and believe that it provides a great service to the public by providing legitimate education about cell therapy in the veterinary field and how this can assist the field of human stem cell therapy.    

Share